Skip to main content

Post-IPO Equity Medical Companies

Explore 243 medical startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
243
Total Funding
$3.5B
Avg Funding
$139.2M
Cities
18

Export 243 Post-IPO Equity Medical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Fort Worth, United States
$11.0M
raised

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$200.0M
raised

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hayward, United States
$250.0M
raised

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$450.0M
raised

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$7.2M
raised

OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$25.0M
raised

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland
$86.6M
raised

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$1.1M
raised

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Irvine, United States
$172.5M
raised

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States
$4.0M
raised

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Morgan Hill, United States
$2.9M
raised

Tenon Medical is a biotechnology company that optimizes SI joint surgical solutions.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$380.0M
raised

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$3.7M
raised

EDX Medical Group provides innovative digital diagnostic products and services.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$150.0M
raised

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$23.5M
raised

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$375.1M
raised

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States
$972K
raised

Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$200.0M
raised

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Cue Biopharma is a developer of a productive platform for the treatment of cancer and autoimmune disease.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$3.3M
raised

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 243 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$15.0M
raised

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$1.0B
raised

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$4.4M
raised

Medicenna is a clinical stage, privately held, immuno-oncology company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$6.1M
raised

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 243 companies

Ready to Connect with Post-IPO Equity Medical Startups?

Get verified founder emails, funding details, and company data for 243 post-ipo equity medical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked